Adverse Drug Reaction Clinical Trial
Official title:
Adverse Drug Reactions With Fatal Outcome
Verified date | July 2016 |
Source | Germans Trias i Pujol Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | Spain: Comité Ético de Investigación Clínica |
Study type | Observational |
The purpose of this study is to determine the incidence of drug-related deaths in a university hospital during the year 2015
Status | Completed |
Enrollment | 1135 |
Est. completion date | July 2016 |
Est. primary completion date | June 2016 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: - inpatients deaths and drug-related deaths. Exclusion Criteria: - death patients in the emergency room, patients with a death diagnosis not available, and dead patients due to other causes non-drug related. |
Observational Model: Cohort, Time Perspective: Retrospective
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Germans Trias i Pujol Hospital |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Incidence of drug-related deaths of all hospital admissions | during the year 2015 | Yes | |
Secondary | Number of drug-related deaths with the suspected drug started the previous week | during the year 2015 | Yes | |
Secondary | Number of drug-related deaths with drug interactions between suspected drugs | during the year 2015 | Yes | |
Secondary | Number of preventable drug-related deaths assessed by Schumock criteria | during the year 2015 | Yes | |
Secondary | Number of drug-related deaths with polypharmacy | Polypharmacy: when patient received >10 drugs | during the year 2015 | Yes |
Secondary | Number of drug-related deaths with autopsy | during the year 2015 | Yes | |
Secondary | Number of drug-related deaths in which the suspected drug had a contributive role | during the year 2015 | Yes | |
Secondary | Number of drug-related deaths with "certain" or "probable" categories assessed by World Health Organization (WHO) criteria and Naranjo algorithm | during the year 2015 | Yes | |
Secondary | Number of drug-related deaths presented during hospitalization | during the year 2015 | Yes | |
Secondary | Risk factors of drug-related deaths | risk factors assessed: age, sex, Charlson score, and hospitalization length | during the year 2015 | Yes |
Secondary | Incidence of drug-related deaths of all inpatients deaths | during the year 2015. | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Suspended |
NCT02559960 -
Post-marketing Safety Surveillance of Breviscapine Powder-Injection : a Registry Study
|
||
Completed |
NCT01946919 -
Post-Marketing Surveillance of the Cinepazide Maleate Injection: a Real World Study
|
||
Recruiting |
NCT04154553 -
Pharmacogenetic Testing of Patients With Unwanted Adverse Drug Reactions or Therapy Failure
|
||
Completed |
NCT01732302 -
Educational Intervention to Reduce Drug-related Hospitalizations in Elderly Primary Health Care Patients
|
N/A | |
Completed |
NCT05224804 -
Pharmacists' Knowledge and Attitudes About ADRs Reporting and Pharmacovigilance Practice in Egyptian Hospitals
|
||
Completed |
NCT02297126 -
A Prospective Trial to Assess Cost and Clinical Outcomes of a Clinical Pharmacogenomic Program
|
N/A | |
Completed |
NCT03093818 -
PREemptive Pharmacogenomic Testing for Preventing Adverse Drug REactions
|
N/A | |
Not yet recruiting |
NCT04568668 -
Evaluating ActionADE in Reducing Adverse Drug Reactions
|
N/A | |
Recruiting |
NCT02012504 -
Antidepressant Monotherapy on Depressive and Anxiety Symptom in Chinese Patients
|
Phase 0 | |
Completed |
NCT01872520 -
Post-marketing Safety Surveillance of the Injection of DanShenDuoFenSuanYan A Real World Study
|
N/A | |
Completed |
NCT01467050 -
Prevention of Adverse Drug Events (ADEs) in Hospitalised Older Patients
|
Phase 4 | |
Completed |
NCT01679964 -
Sustained Virological Suppression and Improvement of Adverse Events of Switching to Raltegravir Study
|
Phase 4 | |
Completed |
NCT02094638 -
Post-Marketing Surveillance of the Tanreqing Injection: a Real World Study
|
N/A | |
Recruiting |
NCT01906710 -
the Pharmacy Intervention Team Hospital-based (PITH) for People Study: Effect on Clinical and Economic Outcomes
|
N/A | |
Completed |
NCT02888834 -
Serious Adverse Drug Reaction and Their Preventability
|
N/A | |
Completed |
NCT02159209 -
The Drug Induced Renal Injury Consortium
|
N/A | |
Completed |
NCT02134587 -
Educational Intervention in Pharmacovigilance for Hospital Health Professionals
|
N/A | |
Completed |
NCT04553107 -
Reducing Costs by Deprescribing Medications
|
N/A | |
Recruiting |
NCT06219720 -
The Texas Interprofessional Pharmacogenomics (IPGx)
|
||
Recruiting |
NCT05508763 -
Personalised Therapeutics @LUMC
|